Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Molecules ; 25(19)2020 Oct 02.
Article in English | MEDLINE | ID: mdl-33023106

ABSTRACT

Our recent studies have demonstrated multiple health-promoting benefits from black walnut kernels. These biological functions of black walnuts are likely associated with their bioactive constituents. Characterization of phenolic compounds found in black walnut could point out underexplored bioactive activities of black walnut extracts and promote the development of novel applications of black walnut and its by-products. In the present study, we assessed bioactivity profiles of phenolic compounds identified in the kernels of black walnuts using a high-throughput screening (HTS) approach. Black walnut phenolic compounds were evaluated in terms of their total antioxidant capacity, antioxidant response element (ARE) induction, and anticancer activities. The anticancer activities were identified by evaluating the effects of the phenolic compounds on the growth of the tumorigenic alveolar epithelial cells (A549) and non-tumorigenic lung fibroblast cells (MRC-5). Out of 16 phenolic compounds tested, several compounds (penta-O-galloyl-ß-d-glucose, epicatechin gallate, quercetin, (-)-epicatechin, rutin, quercetin 3-ß-d-glucoside, gallic acid, (+)-catechin, ferulic acid, syringic acid) exerted antioxidant activities that were significantly higher compared to Trolox, which was used as a control. Two phenolic compounds, penta-O-galloyl-ß-d-glucose and quercetin 3-ß-d-glucoside, exhibited antiproliferative activities against both the tumorigenic alveolar epithelial cells (A549) and non-tumorigenic lung fibroblast cells (MRC-5). The antioxidant activity of black walnut is likely driven not only by penta-O-galloyl-ß-d-glucose but also by a combination of multiple phenolic compounds. Our findings suggested that black walnut extracts possibly possess anticancer activities and supported that penta-O-galloyl-ß-d-glucose could be a potential bioactive agent for the cosmetic and pharmaceutical industries.


Subject(s)
Antineoplastic Agents/analysis , Antineoplastic Agents/pharmacology , Antioxidants/analysis , Antioxidants/pharmacology , High-Throughput Screening Assays/methods , Juglans/chemistry , Phenols/pharmacology , Cell Death/drug effects , Cell Proliferation/drug effects , Hep G2 Cells , Humans , Inhibitory Concentration 50 , Response Elements/genetics
2.
Sci Rep ; 13(1): 18860, 2023 11 01.
Article in English | MEDLINE | ID: mdl-37914763

ABSTRACT

Glansreginin A has been reported to be an indicator of the quality of walnuts (Juglans spp.). However, bioactive properties of glansreginin A have not been adequately explored. In the present study, we quantified concentrations of glansreginin A in black walnuts (Juglans nigra) using high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) and performed an array of in vitro bioassays to characterize biological activities (e.g., antibacterial, antioxidant, anticancer capacities) of this compound. Results from HPLC-MS/MS analysis indicated that glansreginin A was presented in all 12 black cultivars examined and its contents were variable among black walnut cultivars, ranged from 6.8 mg/kg (Jackson) to 47.0 mg/kg (Hay). Glansreginin A possessed moderate antibacterial activities against Gram-positive pathogens (Staphylococcus aureus and Bacillus anthracis). This compound exhibited no antioxidant activities, did not induce the activity of antioxidant response element signaling pathways, and exerted no antiproliferative effects on tumorigenic alveolar epithelial cells and non-tumorigenic lung fibroblast cells.


Subject(s)
Juglans , Quinolines , Juglans/chemistry , Tandem Mass Spectrometry/methods , Antioxidants/pharmacology , Antioxidants/chemistry , Anti-Bacterial Agents/pharmacology
3.
Clin Pediatr (Phila) ; 61(2): 184-187, 2022 02.
Article in English | MEDLINE | ID: mdl-34859706

ABSTRACT

The objective of this study was to characterize the clinical presentation and outcomes of children and adolescents testing positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the ambulatory setting. We found that about 8% of children tested positive for SARS-CoV-2, with the large majority being symptomatic (80%). The average age of our population was 12.5 years, and females and males were affected equally. However, African American patients (62%) were substantially more likely to test positive compared with other races. Children in this study tended to have a mild course, mostly presenting with respiratory symptoms, and very few required hospitalization. As the epidemiology of the pandemic evolves, it will be important to monitor the effects that changing variants have on infected children and the impact that vaccination programs have on mitigating infection risk.


Subject(s)
Ambulatory Care Facilities/statistics & numerical data , COVID-19/diagnosis , Adolescent , Ambulatory Care Facilities/organization & administration , COVID-19/epidemiology , Child , Child, Preschool , Female , Hospitalization/statistics & numerical data , Humans , Male , Maryland/epidemiology , Young Adult
4.
Diabetes ; 63(9): 3112-9, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24705405

ABSTRACT

Patients with type 2 diabetes demonstrate reduced functional connectivity within the resting state default mode network (DMN), which may signal heightened risk for cognitive decline. In other populations at risk for cognitive decline, additional magnetic resonance imaging abnormalities are evident during task performance, including impaired deactivation of the DMN and reduced activation of task-relevant regions. We investigated whether middle-aged type 2 diabetic patients show these brain activity patterns during encoding and recognition tasks. Compared with control participants, we observed both reduced 1) activation of the dorsolateral prefrontal cortex during encoding and 2) deactivation of the DMN during recognition in type 2 diabetic patients, despite normal cognition. During recognition, activation in several task-relevant regions, including the dorsolateral prefrontal cortex and DMN regions, was positively correlated with HbA1c and insulin resistance, suggesting that these important markers of glucose metabolism impact the brain's response to a cognitive challenge. Plasma glucose ≥11 mmol/L was associated with impaired deactivation of the DMN, suggesting that acute hyperglycemia contributes to brain abnormalities. Since elderly type 2 diabetic patients often demonstrate cognitive impairments, it is possible that these task-induced brain activity patterns observed in middle age may signal impending cognitive decline.


Subject(s)
Cognition Disorders/etiology , Diabetes Mellitus, Type 2/complications , Biomarkers , Brain/physiology , Brain Mapping , Female , Humans , Magnetic Resonance Imaging/methods , Male , Middle Aged , Neuropsychological Tests
SELECTION OF CITATIONS
SEARCH DETAIL